Latest Insider Transactions at 2seventy Bio, Inc. (TSVT)
This section provides a real-time view of insider transactions for 2seventy Bio, Inc. (TSVT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of 2seventy bio, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of 2seventy bio, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 13
2025
|
Sarah Js Glickman |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
15,602
-100.0%
|
-
|
|
May 13
2025
|
Sarah Js Glickman |
SELL
Sale (or disposition) back to the issuer
|
Direct |
12,050
-43.58%
|
-
|
|
May 13
2025
|
Casdin Capital, LLC Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
2,000,000
-100.0%
|
$10,000,000
$5.0 P/Share
|
|
May 13
2025
|
Casdin Capital, LLC Director |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
22,625
-100.0%
|
$113,125
$5.0 P/Share
|
|
May 13
2025
|
Lin Wei |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
15,267
-100.0%
|
-
|
|
May 13
2025
|
Lin Wei |
SELL
Sale (or disposition) back to the issuer
|
Direct |
17,583
-53.53%
|
-
|
|
May 13
2025
|
Jessica Snow Chief Operating Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
11,064
-100.0%
|
-
|
|
May 13
2025
|
Jessica Snow Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
247,230
-95.72%
|
-
|
|
May 13
2025
|
Victoria Eatwell Chief Financial Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
43,276
-100.0%
|
-
|
|
May 13
2025
|
Victoria Eatwell Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
401,111
-90.26%
|
-
|
|
May 13
2025
|
Nick Leschly |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Indirect |
56,233
-100.0%
|
-
|
|
May 13
2025
|
Nick Leschly |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
897,642
-100.0%
|
-
|
|
May 13
2025
|
Nick Leschly |
SELL
Sale (or disposition) back to the issuer
|
Direct |
335,964
-27.23%
|
-
|
|
May 13
2025
|
William D Baird Iii President and CEO |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
118,209
-100.0%
|
-
|
|
May 13
2025
|
William D Baird Iii President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,002,825
-89.46%
|
-
|
|
May 13
2025
|
Denice Torres |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
19,510
-100.0%
|
-
|
|
May 13
2025
|
Denice Torres |
SELL
Sale (or disposition) back to the issuer
|
Direct |
12,050
-38.18%
|
-
|
|
May 13
2025
|
Charles W. Newton |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
5,533
-100.0%
|
-
|
|
May 13
2025
|
Charles W. Newton |
SELL
Sale (or disposition) back to the issuer
|
Direct |
17,092
-75.54%
|
-
|
|
May 13
2025
|
Marcela V. Maus |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
11,702
-100.0%
|
-
|
|
May 13
2025
|
Marcela V. Maus |
SELL
Sale (or disposition) back to the issuer
|
Direct |
12,050
-50.73%
|
-
|
|
Mar 17
2025
|
Victoria Eatwell Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,592
-0.58%
|
$10,368
$4.95 P/Share
|
|
Mar 17
2025
|
William D Baird Iii President and CEO |
SELL
Open market or private sale
|
Direct |
5,092
-0.45%
|
$20,368
$4.95 P/Share
|
|
Mar 17
2025
|
Jessica Snow Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,298
-0.9%
|
$9,192
$4.95 P/Share
|
|
Mar 11
2025
|
Kynam Global Healthcare Master Fund, LP > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
11,095,936
-100.0%
|
$44,383,744
$4.93 P/Share
|
|
Mar 11
2025
|
Kynam Global Healthcare Master Fund, LP > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
5,142,111
-100.0%
|
$20,568,444
$4.93 P/Share
|
|
Jan 07
2025
|
Jessica Snow Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
186
-0.13%
|
$372
$2.64 P/Share
|
|
Jan 06
2025
|
William D Baird Iii President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
264,000
+18.99%
|
-
|
|
Jan 06
2025
|
Victoria Eatwell Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
108,000
+19.46%
|
-
|
|
Jan 06
2025
|
Jessica Snow Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
106,150
+29.53%
|
-
|
|
Jan 06
2025
|
William D Baird Iii President and CEO |
SELL
Open market or private sale
|
Direct |
763
-0.09%
|
$1,526
$2.78 P/Share
|
|
Jan 06
2025
|
Victoria Eatwell Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
97
-0.03%
|
$194
$2.78 P/Share
|
|
Jan 06
2025
|
Nick Leschly |
SELL
Open market or private sale
|
Direct |
892
-0.07%
|
$1,784
$2.78 P/Share
|
|
Jan 06
2025
|
Jessica Snow Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
5,114
-1.68%
|
$10,228
$2.79 P/Share
|
|
Jan 03
2025
|
William D Baird Iii President and CEO |
SELL
Open market or private sale
|
Direct |
31,718
-3.55%
|
$63,436
$2.94 P/Share
|
|
Jan 03
2025
|
Victoria Eatwell Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,013
-0.3%
|
$2,026
$2.94 P/Share
|
|
Jan 03
2025
|
Nick Leschly |
SELL
Open market or private sale
|
Direct |
85,978
-6.51%
|
$171,956
$2.94 P/Share
|
|
Jan 03
2025
|
Jessica Snow Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,000
-0.65%
|
$2,000
$2.94 P/Share
|
|
Dec 13
2024
|
Jessica Snow Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,287
-1.47%
|
$6,861
$3.23 P/Share
|
|
Nov 18
2024
|
Marcela V. Maus |
SELL
Open market or private sale
|
Direct |
3,900
-14.1%
|
$11,700
$3.38 P/Share
|
|
Oct 03
2024
|
Victoria Eatwell Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,230
-0.36%
|
$4,920
$4.65 P/Share
|
|
Oct 03
2024
|
Jessica Snow Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
679
-0.43%
|
$2,716
$4.65 P/Share
|
|
Aug 14
2024
|
Jessica Snow Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
7,816
-4.76%
|
$31,264
$4.32 P/Share
|
|
Aug 05
2024
|
Victoria Eatwell Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
13
-0.0%
|
$39
$3.98 P/Share
|
|
Jul 02
2024
|
Jessica Snow Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
14
-0.01%
|
$56
$4.02 P/Share
|
|
Jul 02
2024
|
Victoria Eatwell Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
12
-0.0%
|
$48
$4.02 P/Share
|
|
Jul 01
2024
|
Jessica Snow Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
108,538
+39.8%
|
-
|
|
Jul 01
2024
|
William D Baird Iii President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
586,022
+39.58%
|
-
|
|
Jul 01
2024
|
Victoria Eatwell Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
245,864
+41.87%
|
-
|
|
Jun 10
2024
|
Denice Torres |
BUY
Grant, award, or other acquisition
|
Direct |
12,050
+27.63%
|
-
|